INOVIO PHARMACEUTICALS, INC. Tax Withholding Paid on Stock Awards
INOVIO PHARMACEUTICALS, INC. (INO) reported Tax Withholding Paid on Stock Awards of $466.65 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2023-11-09
- INOVIO PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-09-30 was $9.65K, a 79.85% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-06-30 was $32.29K, a 90.01% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2023-03-31 was $424.70K, a 58.62% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2022-09-30 was $47.90K, a 93.12% decline year-over-year.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 3 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month |
|---|---|---|---|---|
| 2023-09-30 | $9.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $41.94K derived: sum of 2 quarters · filed 2023-11-09 | $466.65K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $32.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $457.00K 10-Q · filed 2023-08-09 | ||
| 2023-03-31 | $424.70K 10-Q · filed 2023-05-10 | |||
| 2022-09-30 | $47.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $371.30K derived: sum of 2 quarters · filed 2023-11-09 | $1.40M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $323.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.35M 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | $1.03M 10-Q · filed 2023-05-10 | |||
| 2021-09-30 | $696.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $776.56K derived: sum of 2 quarters · filed 2022-11-08 | $4.61M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $80.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.92M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $3.83M 10-Q · filed 2022-05-10 | |||
| 2020-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.96M derived: sum of 2 quarters · filed 2021-11-09 | $4.03M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $3.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $2.08M 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $2.07M 10-Q · filed 2021-05-10 | |||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $161.20K derived: sum of 2 quarters · filed 2020-11-09 | $892.93K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $161.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $892.93K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $731.73K 10-Q · filed 2020-05-11 | $719.40K 10-Q · filed 2019-05-09 | ||
| 2018-03-31 | $506.40K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |